We investigated the role of autophagy in the extended lifespan induced by germline removal in
C. elegans, and shown using multiple complimentary approaches that germline-less
glp-1 animals display increased levels of autophagic events. We also detected that the increase in the expression of several autophagy genes was dependent on the FOXA transcription factor PHA-4, suggesting that autophagy is induced at the transcriptional level in response to germline removal. Accordingly, autophagy genes and
pha-4 were required for
glp-1 animals to live long. Taken together, these observations indicate that autophagy is induced in a beneficial manner in germline-less animals. While we detected autophagy by using steady-state methods, our data strongly argue for a functional role for autophagy turnover in germline-deficient animals because we obtain the same effects on long-lived
glp-1 animals after RNAi against genes that act in multiple steps of the autophagy process. Consistent with this interpretation, we find that TOR, a known negative regulator of autophagy, is downregulated in
glp-1 animals. As reduced TOR signaling plays an important role in other
C. elegans longevity models that rely on autophagy genes, such as dietary restriction [
10-
12], these observations suggest a broader role for the TOR-regulated process of autophagy in preventing aging in
C. elegans.
The FOXO transcription factor DAF-16 is essential for lifespan extension through germline removal [
2], yet we find that autophagy gene expression and autophagy itself remained high in
glp-1 animals lacking
daf-16. Thus, in contrast to lifespan extension, induction of autophagy appears to be independent of
daf-16 in these animals, similar to our previous observations in long-lived
daf-2 insulin/IGF-1 receptor mutants [
11]. These results suggest that
daf-16 may act downstream of, or in parallel with, autophagy function in such long-lived animals. Nevertheless, DAF-16 is required to obtain the beneficial effects of autophagy on longevity in
glp-1 animals. As discussed previously [
11], we speculate that DAF-16 could play a regulatory role in the recycling of material from the autophagic process into new targets that have beneficial effects on longevity. This situation is different from overexpression of DAF-16, which is sufficient to induce autophagy in
C. elegans [
22], possibly because DAF-16 may be activated by different mechanisms in animals overexpressing DAF-16 than in
glp-1 animals. Other proteins such as PHA-4 may induce autophagy in germline-less animals in the presence or absence of
daf-16 activity. Specifically, we find that the expression of several autophagy genes (i.e.,
unc-51, lgg-1, and
bec-1) is increased in
glp-1 animals compared to wild type, and this induction requires
pha-4. Consistent with these observations, we observed
pha-4 to be required for autophagy induction in germline-less animals. Notably, we found that overexpression of PHA-4 significantly induced
unc-51 but not
lgg-1 and
bec-1 levels (
Fig. S6), suggesting that PHA-4 overexpression is sufficient to recapitulate some, but not all of the PHA-4 mediated effects observed in
glp-1 animals. These experiments not only reveal a novel mechanism by which autophagy is induced in
C. elegans, but also suggest that PHA-4 regulates the transcription of autophagy genes in metazoans. In support of this possibility, PHA-4 was recently shown to bind to the promoters of multiple autophagy genes, including
unc-51, bec-1, and
lgg-1 during development [
23,
24] (see also
Supplemental Information). Moreover, PHA-4 is required for the increase in autophagy observed in long-lived, dietary-restricted
eat-2 mutants [
11]. Taken together, these observations are consistent with PHA-4 modulating lifespan by directly inducing autophagy gene expression, but PHA-4 may also regulate additional targets to affect longevity in germline-less animals. It will be of interest to determine how DAF-16 and PHA-4 function in the same longevity model and whether they regulate certain shared targets [
19], as well as to ask if PHA-4 also regulates autophagy in higher organisms.
In an effort to better understand how autophagy influences lifespan in germline-less animals, we have identified a new role for autophagy in modulating lipid metabolism in
glp-1 animals through the predicted triacylglycerol lipase LIPL-4. We determined that LIPL-4 exhibits lipase activity, at least
in vitro, and significantly contributes to the elevated lipase activity observed in
glp-1 animals. Importantly, we found that autophagic activity as well as autophagy genes and
pha-4 mRNA levels were increased in long-lived animals overexpressing LIPL-4 and that autophagy genes and
pha-4 were required for the elevated lipase activity, as was observed in
glp-1 mutants. As further support for a link between autophagy and LIPL-4, we observed that
lipl-4 is required for the increased autophagy activity observed in
glp-1 animals and thus an increase in LIPL-4 activity may promote autophagosome formation. In addition, we found that LIPL-4 was expressed in the same tissues in which we detected increased autophagy in germline-less animals, namely hypodermal seam cells and the intestine. Finally, the autophagy regulator TOR might function as a common upstream regulator of these two processes in germline-less animals, as we discovered that inhibition of TOR was sufficient to increase
lipl-4 levels and lipase activity in a
daf-16-dependent fashion, indicating that TOR has both
daf-16-dependent as well as
daf-16-independent functions [
21,
25]. Collectively, these results strongly support the existence of a novel link between autophagy and LIPL-4 in germline-less
C. elegans (see model in ).
Our results further suggest that the connection between autophagy and LIPL-4 in germline-deficient
C. elegans may be critical for lifespan extension in these animals. We found that LIPL-4 overexpressing animals are long-lived and both
pha-4 and autophagy genes are required for this extended lifespan, as is the case for
glp-1 animals. Although we do not yet know how LIPL-4 overexpression may induce autophagy to extend lifespan, it is possible that a lipase metabolite could trigger autophagy through regulation of TOR signaling (similarly to phosphatidic acid, a product of phospholipase D activity [
26]) via an increase in PHA-4 activity. Such an explanation is consistent with the observation that directly reducing TOR levels by RNAi failed to extend lifespan in adult LIPL-4 overexpressing animals (
Table S2), and LIPL-4 overexpressing animals have increased
pha-4 mRNA levels. As further evidence for autophagy and LIPL-4 working by overlapping mechanisms, we observed that simultaneous inhibition of both lipase and autophagy functions did not further decrease the lifespan of
glp-1 animals, compared to inhibiting each process separately. Taken together, our genetic and biochemical analyses are consistent with a model in which LIPL-4 and autophagy work in concert to extend the lifespan of
glp-1 animals.
In this model (
), the activity of the nutrient sensor TOR is reduced in response to germline removal, and this triggers the induction of two different pathways. One pathway involves activation of DAF-16 to induce
lipl-4 expression, which again may increase lipid hydrolysis. In contrast, the other pathway causes an induction of PHA-4 and subsequent autophagy gene expression to ensure increased flux through the multi-step autophagy process. We note that feedback and crosstalk between components of these two pathways are possible. For example, we find that LIPL-4 overexpression causes a small (1.5 to 2-fold) increase in
daf-16 mRNA levels, and inhibition of
pha-4 by RNAi reduces
lipl-4 mRNA levels to about 50% in
glp-1 animals (data not shown). Consistent with the latter observation, PHA-4 can bind the
lipl-4 promoter [
23,
24]. Taken together, these data suggest that
lipl-4 could be a common target of both DAF-16 and PHA-4. In turn, autophagy and LIPL-4 might work interdependently to ensure lifespan extension in germline-less animals.
What is the nature of the link between autophagy and LIPL-4, which may possess intracellular lipolytic activity, and how could this link lead to lifespan benefits? One possible mechanism may involve lipophagy, which is a large-scale hydrolysis of neutral lipid stores in the lysosome [
13]. This scenario would predict lipases to be localized to the lysosome as seen for human lysosomal acid lipase, which we note shares a very high degree of sequence homology to LIPL-4. Alternatively, autophagy may be induced by a product of lipase activity, as is the case for autophagy induced by free fatty acids in pancreatic beta cells [
27]. In this case, the lipase could be localized to the autophagosome, as has been observed for phospholipase D1 during starvation of mammalian cells [
28]. It is also possible that enhanced lipolysis via autophagy prevents the accumulation of toxic byproducts or is critical for the partitioning of unused yolk, normally destined for oocytes. Lipolysis could process phospholipids to boost membrane formation for autophagosome maturation necessary to recycle components relevant to aging. Future experiments, including cytological and biochemical profiling of lipids in
glp-1 and LIPL-4-overexpressing animals, should help clarify how autophagy is linked to lipid metabolism in germline-less animals, including determining the intracellular function of LIPL-4.
Taken together, this study proposes a potential mechanism by which autophagy affects lifespan: we suggest that autophagy and LIPL-4 modulate aging in germline-deficient C. elegans by maintaining lipid homeostasis to prolong lifespan. As such, our results advance our understanding of how autophagy affects organismal aging, and also offer new ideas as to how the regulation of lipid metabolism may be relevant to future treatments of metabolic disorders.